Search

30 January 2012 (Edinburgh) 'The complexity of science and innovation policy'

12 December 2011 (Edinburgh) "Citizen Deliberation and Politics of Risk Assessment: Technical Knowledge in Social-Cultural Context"

31 October 2011 (Edinburgh) - With Regard to Innovation…..Getting the Regulatory Environment Right

10 October 2011 (Edinburgh) REMEDiE: the boundaries and mobilities of regenerative medicine

18 July 2011 Upstream engagement with science and technology: Opportunities and challenges: A mini-symposium

04 May 2011 'Food Portfolios, Resilient Food Systems and Food Security’

11 April 2011 (Edinburgh) - ‘Socio-ethical aspects of the IVF-stem cell interface: the case of ‘egg sharing’ for somatic cell nuclear transfer research.’

14 March 2011 'The Challenges of Interdisciplinarity'

14 February 2011 'Regulatory frameworks in support of emerging healthcare technologies'

14 February 2011 ESRC Seminar Series on Synthetic Biology and the Social Sciences - Seminar 1: Defining the agenda

03 May 2010 (Edinburgh) - 'The organising of clinical trials and the reliability of knowledge'

22 February 2010 (Edinburgh) - 'A short walk with civil servants: of pigs, horses and other animals'

17 February 2010 Learning to export: building smallholder farmers' capabilities through farmer - exporter partnerships in Kenya's cut flower Industry

04 February 2010 Designing synthetic biology

14 December 2009 (Edinburgh) - "Postgenomic Darwinism and Human Nature"

25 November 2009 Western models of health system strengthening in Africa medicine, management and technology

03 November 2009 An Enquiry into Biosafety Regulations Implementation in Kenya: Perspectives and Roles of Scientists

30 October 2009 Opportunity or threat? Disagreements in the identification and avoidance of risk

20 September 2009 Opportunity or threat? Disagreements in the identification and avoidance of risk

06 July 2009 THeSyS Seminar Series: Interdisciplinarity, partnerships and making bioscience innovations in health work for the poor: what lessons can be shared between the North and the South?

02 July 2009 "What is 'civic translational science' and how is it more readily achieved?"

15 May 2009 (Edinburgh) - Prof Zxy-Yann Jane Lu, National Yang-Ming University

13 May 2009 Knowledge accumulation for vaccine innovation: Lessons from polio and HIV/AIDS

27 April 2009 (Edinburgh) - Dr Paul Nightingale, SPRU, University of Sussex

25 February 2009 (Edinburgh) - Prof Richard Ashcroft & Prof Graeme Laurie

21 January 2009 Knowledge and Innovation for Inclusive Development

19 January 2009 (Edinburgh) - Prof Nicola Dimitri, University of Siena

04 December 2008 (Edinburgh) - Prof Richard Ashcroft & Prof Graeme Laurie

17 November 2008 (Edinburgh) - Professor Andrew Webster, University of York

10 September 2008 (Milton Keynes) - Dr Wilmot James

08 September 2008 "(Un)making pharmaceutical futures: why we need to reimagine the drug innovation process"

14 May 2008 The African Union's Biotechnology Strategy

14 April 2008 Innogen Seminar: "Can big pharma survive new biology?"

02 April 2008 INNOGEN SEMINAR: Papa Andina Initiative: 'Stimulating pro poor innovation within the potato market chain in the Andean region'

07 November 2007 Watchdogs of the Public Interest - the role of science journalists and other science communicators

09 October 2007 Scenario Planning, Backcasting, and Transition Management for Sustainable Development

08 October 2007 A personal narrative of travels through the Genomic Continent

25 September 2007 Data in context: the vicissitudes of vaccine innovation

07 May 2007 Beyond validity and utility: thinking sociologically about the usefulness of genetic tests

05 April 2007 A framework for using genome wide scanning in drug development: the right drug for the right patient at the right dose

02 April 2007 CoPS revisited: ten years of the ESRC’s Complex Product Systems Innovation Centre

05 March 2007 UK DonorLink Register Two Years on – Using DNA to link adults genetically related through donor conception

05 February 2007 Why are biological objects so hard to define?

08 January 2007 BiDil, subgroup analyses, and the limits of evidence-based medicine

11 December 2006 Public Views on Biotechnology Applications in China

16 October 2006 Genetics and the Division of Semantic Labour

07 June 2006 Tangible Affinities? Exploring Real Life Kinship

08 May 2006 Patients, Profits and Values: Genzyme and the Creation of Informed Consumers of Potential Innovations

03 April 2006 The Marketing of Genetic Identity

13 March 2006 Cord Blood Banking – new economies of hope and promise in stem cell innovation

08 March 2006 Isolating the ‘farmer’ effect as a component of the advantage of growing genetically modified varieties in developing countries: A Bt cotton case study from Jalgaon - India

16 February 2006 The Diffusion of an Innovative Vaccine Biotechnology : An Examination of Alternative Regulatory Burdens using System Dynamics

06 February 2006 Kinship, genealogy and genetics

23 January 2006 Can South Africa lead the biotechnology revolution in Africa

23 January 2006 Transforming Biorisks and the Commercialization of Human Genetic Testing

10 June 2005 Seminar Series 2005/06

13 April 2005 Research organisation and research success: responding to rice blast in the Mekong Delta

11 April 2005 Risk-related judgements and decisions about GM food: The role of affect

01 April 2005 Workshop on Clusters and Innovation Processes in Genomics

25 February 2005 Judgment under Siege: The Three-Body Problem of Expert Legitimacy

16 February 2005 Not-me-gov-Risk-and-blame-in-public-sector-information-sharing

01 December 2004 Hierarchy in Organisations: It’s Impact on Innovation, Governance and Stakeholder Interactions

08 November 2004 Public Engagement with Genomics

03 November 2004 The Development of Genomics Capabilities in the Pharmaceutical Industry - an alternative to the revolution model

28 October 2004 Perceived risks, benefits and public deliberation: from ‘GM Nation?’ to Nanotechnology

18 October 2004 Get Beck: In Defence of Risk Analysis

01 September 2004 Classification and Silence

31 August 2004 Cyberinfrastructure for the Ages

14 June 2004 Public databases and privat(ised) property: public perceptions of privacy in relation to human genetic databases

19 May 2004 Categorisation of GM foods: deference, essentialism and perspective

26 April 2004 Collaboration and innovation: the evolution of the UK biotech sector

15 March 2004 Strange bedfellows and usual suspects: mapping the emergent complexity of 'social movement society' engagement with human genetic technologies

16 February 2004 Corporate dominance and agricultural biotechnology: implications for development

14 January 2004 Trading the island laboratory: new geographies of Iceland's genetic heritage

18 December 2003 Coping with the social perception of risk. An overview

20 November 2003 Regulating Biotechnology in the Name of Security

03 November 2003 The work of the BIOS Centre

15 October 2003 The utility of genomic knowledge: patenting and commercialisation

16 September 2003 Experts, Non-experts and the Politics of GM Food

12 June 2003 Do bio-pharmaceuticals offer a therapeutic advance over small chemical drugs?

28 March 2003 Innovation, Growth and Market Structure

27 February 2003 From mousetraps to (onco)mice: the international politics of biotech patents

13 May 2009 Knowledge accumulation for vaccine innovation: Lessons from polio and HIV/AIDS

October TBC - (Edinburgh) Dr Mark Cutter, University of Central Lancashire